Inhibitors of Chronically Active Ras: Potential for Treatment of Human Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|3|1|31-47

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.3, Iss.1, 2008-01, pp. : 31-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-01 ,pp. : 683-696

Bentham Science Publishers

Access to resources Recommend Favorite

Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies

By Beck Amanda K   Pass Harvey I   Carbone Michele   Yang Haining  

Future Oncology, Vol. 4, Iss. 3, 2008-06 ,pp. : 341-349

Future Medicine

Access to resources Recommend Favorite

Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 3, 2002-01 ,pp. : 387-401

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors in Pediatric Malignancies

By Skolnik Jeffrey   Adamson Peter  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 606-612

Informa Healthcare

Access to resources Recommend Favorite

Anthracyclines in the Treatment of Gynecologic Malignancies

By Maluf F.C.   Spriggs D.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 18-31

Elsevier

Access to resources Recommend Favorite